TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 29933533

Group type: EXPERIMENTAL
Intervention: Sancai powder
Number of subjects: 132

Group type: COMPARATOR
Intervention: Metformin (1500 mg/day)
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Sancai powder and Metformin
Number of subjects: 132
Study: 22540957

Group type: EXPERIMENTAL
Intervention: Strength Training (ST) twice/week for 21 weeks (STW)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Strength Training (ST) once/week for 21 weeks (STWx1)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Strength Training (ST) twice/week for 21 weeks (STWx2)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Strength Training (STM) twice/week for 21 weeks
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Strength Training (STMx1) once/week for 21 weeks
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: Strength Training (STMx2) twice/week for 21 weeks
Number of subjects: 135

Group type: COMPARATOR
Intervention: Control group (CW and CM)
Number of subjects: 135
Study: 21940766

Group type: EXPERIMENTAL
Intervention: Endothelin receptor antagonists (ERAs)
Number of subjects: 1130

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1130
Study: 22403986

Group type: EXPERIMENTAL
Intervention: 8.0% arginine, calcium carbonate, and 1450 ppm fluoride dentifrice
Number of subjects: 12

Group type: COMPARATOR
Intervention: 8% strontium acetate and 1040 ppm fluoride dentifrice
Number of subjects: 12
Study: 18971722

Group type: EXPERIMENTAL
Intervention: Reconstructive surgery for prominent ears
Number of subjects: 42

Group type: COMPARATOR
Intervention: Leg lengthening surgery (comparison group)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (schoolchildren)
Number of subjects: 42
Study: 16430676

Group type: EXPERIMENTAL
Intervention: Rehabilitation knee brace for 12 weeks post-operatively
Number of subjects: 60

Group type: COMPARATOR
Intervention: No brace, mobilized immediately, crutches discarded 2 weeks post-operatively
Number of subjects: 60
Study: 12618584

Group type: EXPERIMENTAL
Intervention: Elite premenarcheal gymnasts
Number of subjects: 60

Group type: COMPARATOR
Intervention: Age-matched controls
Number of subjects: 60
Study: 10719950

Group type: EXPERIMENTAL
Intervention: Edrophonium (500 microg/kg)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Neostigmine (50 microg/kg)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 18
Study: 8874675

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy (PHT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Acupuncture therapy (AP)
Number of subjects: 0
Study: 1343111

Group type: EXPERIMENTAL
Intervention: Felodipine (oral solution, conventional tablets, extended release tablets)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: Felodipine (various formulations)
Number of subjects: 140
Study: 6589119

Group type: EXPERIMENTAL
Intervention: Volume-cycled ventilation
Number of subjects: 0

Group type: COMPARATOR
Intervention: High-frequency jet ventilation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Both types of ventilator
Number of subjects: 0
Study: 30049247

Group type: EXPERIMENTAL
Intervention: Openly hostile resistance at Session 10
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Hostile resistance at Session 2
Number of subjects: 71
Study: 29587662

Group type: EXPERIMENTAL
Intervention: 0.5% colchicine cream for 10 days
Number of subjects: 36

Group type: COMPARATOR
Intervention: MAL-PDT (methyl aminolevulinate photodynamic therapy)
Number of subjects: 36
Study: 27508135

Group type: EXPERIMENTAL
Intervention: Apo‐Cetirizine 10 mg tablet daily
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sequential regimen of cetirizine 10 mg tablet, loratadine 10 mg tablet and chlorpheniramine 4 mg tablet, one tablet each day
Number of subjects: 54
Study: 24853544

Group type: EXPERIMENTAL
Intervention: Aquaphor
Number of subjects: 491

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil
Number of subjects: 491

Group type: COMPARATOR
Intervention: Untreated control group
Number of subjects: 491
Study: 23145952

Group type: EXPERIMENTAL
Intervention: Tigecycline (100 mg initial dose, then 50 mg IV every 12 hrs)
Number of subjects: 531

Group type: COMPARATOR
Intervention: Ampicillin-sulbactam (1.5-3 g IV every 6 hrs) or Amoxicillin-clavulanate (1.2 g IV every 6-8 hrs)
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Tigecycline
Number of subjects: 531

Group type: COMPARATOR
Intervention: Ampicillin-sulbactam or Amoxicillin-clavulanate
Number of subjects: 531
Study: 20737166

Group type: EXPERIMENTAL
Intervention: Eccentric cycling (151 ± 32 W, 487 ± 107 s)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Concentric cycling (148 ± 21 W, 488 ± 79 s)
Number of subjects: 18
Study: 18565418

Group type: EXPERIMENTAL
Intervention: Carotid Endarterectomy (CEA)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Best Medical Management with Aspirin (ASA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive carotid angioplasty and stenting
Number of subjects: 0
Study: 16122072

Group type: COMPARATOR
Intervention: Thin smear microscopy (clinical study)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thin smear microscopy (field trial)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thick smear microscopy (field trial)
Number of subjects: 0
Study: 12100150

Group type: EXPERIMENTAL
Intervention: ACVB regimen (doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisone)
Number of subjects: 2210
Study: 10457543

Group type: EXPERIMENTAL
Intervention: 1 mg oral dose of SR 46349B (5-HT2 antagonist) administered three hours before bedtime
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 8527534

Group type: EXPERIMENTAL
Intervention: Doxycycline (100 mg twice daily for 3 days)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Tetracycline (500 mg four times daily for 7 days)
Number of subjects: 116
Study: 2254723

Group type: EXPERIMENTAL
Intervention: Intensified Conventional Treatment (ICT)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Regular Treatment (RT)
Number of subjects: 97
Study: 6989436

Group type: EXPERIMENTAL
Intervention: Early injection of insulin (30 minutes before breakfast)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Late injection of insulin (5 minutes before breakfast)
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Early injection of insulin
Number of subjects: 9

Group type: COMPARATOR
Intervention: Late injection of insulin
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Both injection regimens
Number of subjects: 9
Study: 31038792

Group type: EXPERIMENTAL
Intervention: Early feeding (liquid diet after 1 hour, solid diet after 4 hours)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Delayed feeding (fasting for 4 hours, liquid diet until 24 hours, soft diet for 48 hours, solid diet after 72 hours)
Number of subjects: 101
Study: 27716673

Group type: EXPERIMENTAL
Intervention: PARO robotic pet therapy
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard activity programs (Control)
Number of subjects: 61
Study: 25672376

Group type: EXPERIMENTAL
Intervention: Bevacizumab and chemotherapy
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Usable DWI data
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: High quality DWI data
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: DWI quality evaluation
Number of subjects: 123
Study: 24030420

Group type: EXPERIMENTAL
Intervention: Transendocardial CD34(+) cell delivery
Number of subjects: 40

Group type: COMPARATOR
Intervention: Intracoronary CD34(+) cell delivery
Number of subjects: 40
Study: 21601010

Group type: EXPERIMENTAL
Intervention: Mindfulness-based stress reduction
Number of subjects: 0
Study: 19800047

Group type: EXPERIMENTAL
Intervention: SNPs associated with COPD susceptibility
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Three SNPs in the IREB2 gene
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Four other IREB2 SNPs
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Seven IREB2 SNPs
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: Main phenotype of interest
Number of subjects: 813

Group type: EXPERIMENTAL
Intervention: IREB2 protein and mRNA
Number of subjects: 813
Study: 15930028

Group type: EXPERIMENTAL
Intervention: 500 mg GTP
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: 1000 mg GTP
Number of subjects: 124

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 124
Study: 12918649

Group type: EXPERIMENTAL
Intervention: Spending 120 minutes each week in restorative activities involving nature
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11044540

Group type: EXPERIMENTAL
Intervention: beta(2)-adrenergic agonist therapy (clenbuterol)
Number of subjects: 61

Group type: COMPARATOR
Intervention: physiological therapy (PT)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: combination of beta(2)-adrenergic agonist and PT
Number of subjects: 61
Study: 9075142

Group type: EXPERIMENTAL
Intervention: Renal allograft recipients
Number of subjects: 33
Study: 8364133

Group type: EXPERIMENTAL
Intervention: Zinc therapy
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 13
Study: 3554590

Group type: EXPERIMENTAL
Intervention: dalargin
Number of subjects: 180

Group type: COMPARATOR
Intervention: tagamet
Number of subjects: 180

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 180
Study: 29182498

Group type: EXPERIMENTAL
Intervention: Cryogen-cooled monopolar radiofrequency therapy (CMRF) at 90 J/cm2
Number of subjects: 108

Group type: COMPARATOR
Intervention: Sham treatment (≤1 J/cm2)
Number of subjects: 108
Study: 27853272

Group type: EXPERIMENTAL
Intervention: Cupping therapy
Number of subjects: 141
Study: 25436350

Group type: EXPERIMENTAL
Intervention: QUEST questionnaire
Number of subjects: 70

Group type: COMPARATOR
Intervention: GerdQ questionnaire
Number of subjects: 70
Study: 23690533

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Mediterranean diet
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Low-fat diet
Number of subjects: 318

Group type: COMPARATOR
Intervention: All diets
Number of subjects: 318
Study: 20857010

Group type: EXPERIMENTAL
Intervention: CloSYS II
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Corsodyl
Number of subjects: 90

Group type: COMPARATOR
Intervention: Polident
Number of subjects: 90

Group type: COMPARATOR
Intervention: Efferdent
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Fittydent
Number of subjects: 90
Study: 19675681

Group type: EXPERIMENTAL
Intervention: History and Physical Examination (H&P) estimates of filling pressures and cardiac index
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: History and Physical Examination (H&P) estimates of RAP
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: History and Physical Examination (H&P) estimates of orthopnea
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Discharge 'cold' or 'wet' profile
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: Measured cardiac index
Number of subjects: 388

Group type: EXPERIMENTAL
Intervention: H&P estimates of cardiac index
Number of subjects: 388
Study: 15533351

Group type: EXPERIMENTAL
Intervention: GnRH analogue plus add-back therapy
Number of subjects: 133

Group type: COMPARATOR
Intervention: GnRH analogue alone
Number of subjects: 133

Group type: COMPARATOR
Intervention: Estroprogestin
Number of subjects: 133
Study: 11878688

Group type: EXPERIMENTAL
Intervention: Remifentanil (group R, n=30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sevoflurane (group S, n=30)
Number of subjects: 60
Study: 9559374

Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nonsmokers
Number of subjects: 25
Study: 7878376

Group type: EXPERIMENTAL
Intervention: Behavioral counselling individualized according to functional analysis
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 3277588

Group type: EXPERIMENTAL
Intervention: One day of cefonicid sodium therapy
Number of subjects: 248

Group type: COMPARATOR
Intervention: Five days of cefonicid sodium therapy
Number of subjects: 248

Group type: COMPARATOR
Intervention: Five days of cefamandole nafate therapy
Number of subjects: 248
Study: 29455298

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day)
Number of subjects: 686

Group type: COMPARATOR
Intervention: Exemestane (25 mg/day)
Number of subjects: 686

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg/day) and Exemestane (25 mg/day)
Number of subjects: 686
Study: 25331064

Group type: EXPERIMENTAL
Intervention: Methylene blue injection into the superior rectal artery
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (palpation and sight)
Number of subjects: 131

Group type: EXPERIMENTAL
Intervention: Methylene blue injection
Number of subjects: 131
Study: 25442722

Group type: EXPERIMENTAL
Intervention: Buffered 2% lidocaine with 1:80,000 epinephrine buffered with 0.18 mL 8.4% sodium bicarbonate
Number of subjects: 80

Group type: COMPARATOR
Intervention: Nonbuffered 2% lidocaine with 1:80,000 epinephrine with 0.18 mL sterile distilled water
Number of subjects: 80
Study: 23678970

Group type: EXPERIMENTAL
Intervention: Surface Perturbation Treadmill Training (SPTT)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard Physical Therapy (Standard PT)
Number of subjects: 73
Study: 21395453

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 343

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 343
Study: 18446549

Group type: EXPERIMENTAL
Intervention: Acupuncture and/or interocclusal appliance therapy
Number of subjects: 65
Study: 17278415

Group type: EXPERIMENTAL
Intervention: Exoneration from blame (exonerated group)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Nonaddressed group (no exoneration)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Neutral discussion group
Number of subjects: 48
Study: 14685445

Group type: EXPERIMENTAL
Intervention: Etoposide in the induction phase
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: German protocol (after 1991)
Number of subjects: 83

Group type: COMPARATOR
Intervention: No intervention (before 1991)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Overall survival
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Continuous complete remission
Number of subjects: 83
Study: 11061985

Group type: EXPERIMENTAL
Intervention: Zafirlukast (40 mg oral)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9490579

Group type: EXPERIMENTAL
Intervention: 6% hydroxyethyl starch (HES)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: 3% gelatin (GEL)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 7
Study: 1539519

Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Ouabain
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Cedilanid
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Procainamide
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (7 patients)
Number of subjects: 39
Study: 3927690

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 17

Group type: COMPARATOR
Intervention: Indomethacin after aspirin treatment
Number of subjects: 17
Study: 31568696

Group type: EXPERIMENTAL
Intervention: Serelaxin treatment
Number of subjects: 1120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: Elevated MELD‐XI score on admission
Number of subjects: 1120

Group type: EXPERIMENTAL
Intervention: MELD‐XI score addition to prognostic model
Number of subjects: 1120
Study: 30345884

Group type: EXPERIMENTAL
Intervention: Olaparib (300 mg twice daily)
Number of subjects: 391

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 391
Study: 27003517

Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab injection (IRI)
Number of subjects: 38
Study: 24461901

Group type: EXPERIMENTAL
Intervention: Salmeterol
Number of subjects: 7376

Group type: COMPARATOR
Intervention: Tiotropium
Number of subjects: 7376
Study: 23246790

Group type: EXPERIMENTAL
Intervention: Web-based intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Printed intervention
Number of subjects: 0
Study: 21526670

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil 0.05/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intrathecal sufentanil
Number of subjects: 60
Study: 17272671

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 35 mmHg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Lower body negative pressure (LBNP) at 15 mmHg
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: BOLD signal changes during LBNP
Number of subjects: 16
Study: 15345982

Group type: EXPERIMENTAL
Intervention: Vented reamed intramedullary nailing
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nonvented reamed intramedullary nailing
Number of subjects: 12
Study: 11594442

Group type: EXPERIMENTAL
Intervention: Caffeinated drink (100 mg caffeine) consumed by the test group when undeprived on days 1-4, tested when caffeine-deprived on day 5.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Caffeinated drink consumed by the deprived control group.
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo drink consumed by the deprived control group.
Number of subjects: 52
Study: 9767255

Group type: EXPERIMENTAL
Intervention: Topical melatonin with vitamins E and C
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical vitamin C alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical vitamin E alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical melatonin alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical combination of vitamins E and C
Number of subjects: 0
Study: 8093132

Group type: EXPERIMENTAL
Intervention: Isosorbide-5-mononitrate (20 mg twice daily)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 2542193

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy (6000 cGy in 30-35 fractions) + BCNU
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy + streptozotocin
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Hyperfractionated (twice daily) radiotherapy (6600 cGy in 60 fractions) + BCNU
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Conventional radiotherapy with misonidazole followed by BCNU
Number of subjects: 603
Study: 30307966

Group type: EXPERIMENTAL
Intervention: Functionally orientated treatment based on the shortened dental arch (SDA) concept
Number of subjects: 89

Group type: COMPARATOR
Intervention: Removable partial dentures (RPDs)
Number of subjects: 89
Study: 28101560

Group type: EXPERIMENTAL
Intervention: Multidisciplinary assessment and individualized rehabilitation interventions
Number of subjects: 308

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 308
Study: 26404420

Group type: EXPERIMENTAL
Intervention: Family-based intervention (N=70)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Information-monitoring control condition (N=66)
Number of subjects: 136
Study: 24548447

Group type: EXPERIMENTAL
Intervention: Individualized chemotherapies based on ERCC1 and TOPO I expression results
Number of subjects: 90

Group type: COMPARATOR
Intervention: Random chemotherapies
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Estimated drug tolerated group (ERCC1 high expression or TOPO I low expression)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Estimated drug sensitive group
Number of subjects: 90
Study: 20577103

Group type: EXPERIMENTAL
Intervention: Early posttrabeculectomy IOP spike ≥5 mm Hg above baseline IOP
Number of subjects: 300

Group type: COMPARATOR
Intervention: No IOP spike
Number of subjects: 300
Study: 18440181

Group type: EXPERIMENTAL
Intervention: Optimal medical care (claudication pharmacotherapy)
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Primary stent placement
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Supervised exercise rehabilitation
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Combined stenting with supervised exercise rehabilitation
Number of subjects: 252

Group type: COMPARATOR
Intervention: All treatment strategies
Number of subjects: 252
Study: 16778617

Group type: EXPERIMENTAL
Intervention: Inclusion of papillary muscles in LV mass calculations
Number of subjects: 100

Group type: COMPARATOR
Intervention: Exclusion of papillary muscles in LV mass calculations
Number of subjects: 100
Study: 12670841

Group type: EXPERIMENTAL
Intervention: On-deflate method without air in the stomach
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: On-deflate method with air in the stomach
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Overall findings
Number of subjects: 70
Study: 16380697

Group type: EXPERIMENTAL
Intervention: Hemodialysis patients
Number of subjects: 30

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hemodialysis
Number of subjects: 30
Study: 10332180

Group type: EXPERIMENTAL
Intervention: Preventive strategies including reduced route march speed (from 7.5 to 5 km/h), running on softer surfaces, promoting individual step length, wider spacing in formations, and interval-running training.
Number of subjects: 161
Study: 7551848

Group type: EXPERIMENTAL
Intervention: Steroid therapy
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (age-matched controls)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Overall treatment outcomes
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Hormone therapy
Number of subjects: 50
Study: 1936511

Group type: EXPERIMENTAL
Intervention: Voltaren Emulgel
Number of subjects: 120

Group type: COMPARATOR
Intervention: Regular gel
Number of subjects: 120
Study: 6182412

Group type: EXPERIMENTAL
Intervention: Nicardipine 5 mg, 10 mg, 20 mg (each given three times daily for 1 week)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nicardipine (higher doses)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Nicardipine (all doses)
Number of subjects: 6
Study: 28248854

Group type: EXPERIMENTAL
Intervention: High-frequency chest wall oscillation (HFCWO)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Conventional chest physical therapy (CCPT)
Number of subjects: 73
Study: 25474232

Group type: EXPERIMENTAL
Intervention: Fibrin glue-assisted conjunctival autograft (CAG)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Fibrin glue-assisted conjunctivolimbal autograft (CLAG)
Number of subjects: 47